Brought to you by 
Antalium Inc. gets seed funding of $195k
24 Nov 2003
Executive Summary
With the aim of developing drugs for pain, Kazimierz Babinsky, PhD and Phillipe Sequela, PhD of McGill's Montreal Neurological Institute have formed Antalium with seed funding of $195,338 (Cdn$300,000).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Antalium Inc. gets seed funding of $195k
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice